학술논문

A phase I study of 2-hydroxyoleic acid (2-OHOA), a novel sphingomyelin synthase activator in patients (pt) with advanced solid tumors (AST) including refractory high grade gliomas/glioblastomas (GBM): Updated results of the expansion
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2016, 34 15, 2p. Supplement: S
Subject
Language
English
ISSN
15277755